Document:

<PAGE>
                                                                    EXHIBIT 10.2
                       CHEROKEE-MOSSIMO FINDERS AGREEMENT

        This Cherokee-Mossimo Finders Agreement ("Agreement") is made and
entered into this 27 day of March 2000 (the "Effective Date") by and between
Cherokee Inc., a Delaware corporation ("Cherokee"), and Mossimo, Inc., a
Delaware corporation ("Mossimo").

        Whereas, Mossimo owns the various Mossimo trademark applications and
registrations listed on Exhibit "A" hereto (the "Mossimo Trademarks"); and

        Whereas, Mossimo and Cherokee have entered into that certain Letter of
Intent dated February 22, 2000 (the "LOI"); and

        Whereas, pursuant to the LOI, Cherokee has introduced Mossimo to such
executives at Target Corporation ("Target") to enable Mossimo to negotiate a
licensing agreement with Target with respect to the Mossimo Trademarks; and

        Whereas, Mossimo and Cherokee desire to extinguish the obligations of
each of the parties set forth in the LOI and to substitute this Agreement as a
novation for the LOI;

        Now, therefore, in consideration of the foregoing and for other good and
valuable consideration, the parties hereto agree as follows:

        1. PRIOR AGREEMENTS. This Agreement is intended by the parties to
supercede and replace all prior agreements or understandings of any type between
the parties (the "Prior Agreements"), including without limitation the letter
agreement dated February 18, 2000 and the LOI, and all such Prior Agreements
shall terminate and be of no further force or effect upon execution of this
Agreement.

                (a) Mossimo and Cherokee (the "Parties") each hereby releases
the other Party and its officers, directors, shareholders, agents,
representatives, servants and employees past, present and future, and each of
them, from any and all obligations, debts, claims, demands and causes of action
of any kind or nature, whether known or unknown, suspected or unsuspected by the
Parties and their respective past, present and future officers, directors,
shareholders, agents, representatives, servants and employees (collectively, the
"Releasers"), which the Releasers or any of them now owns or holds, or has at
any time owned or held or may hereafter own or hold against the other Party or
any of the Releasers, arising out of, related to or in any way connected with
the Prior Agreements.

                (b) It is the intention of the Parties in executing this
instrument that the same shall be effective as a bar to each and every claim,
demand and cause of action hereinabove specified; and in furtherance of this
intention, the Parties hereby expressly waive any and all rights and benefits
conferred upon them by the provisions of Section 1542 of the California Civil
Code and expressly agree that the above releases are intended to and do extend
to and cover claims of the type referred to in said Section 1542, which reads as
follows:

<PAGE>

                        "A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE
                        CREDITOR DOES NOT KNOW OR EXPECT TO EXIST IN HIS FAVOR
                        AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY
                        HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH
                        THE DEBTOR."

        The Parties expressly consent that the above releases shall be given
full force and effect according to each and all of their express terms and
provisions, including as well those relating to the unknown and unsuspected
claims, demands and causes of action hereinabove specified.

        2. EXCLUSIVE NEGOTIATION PERIOD. Mossimo shall not enter into licensing
discussions or negotiations with respect to direct retail licenses with any
person or entity other than the Prospective Licensees (as hereinafter defined)
from the Effective Date until June 21, 2000. Nothing herein shall be construed
to obligate Mossimo to enter into any license agreement with the Prospective
Licensees. Mossimo has the right in its sole and absolute discretion to reject
any license agreement proposed by a Prospective Licensee, and Cherokee shall not
be entitled to any compensation whatsoever, including, but not limited to, under
this Agreement, unless Mossimo enters into a license agreement with a
Prospective Licensee.

        3. FINDER'S FEES.

              (a) COMPUTATION. If Mossimo enters into a direct retail license
agreement with a Prospective Licensee on or before February 21, 2001, Mossimo
shall pay to Cherokee in perpetuity finder's fees (the "Finder's Fees") equal to
fifteen percent (15%) of Net Revenues (as hereinafter defined). No Finder's Fees
will be due if Mossimo does not enter into a license agreement with a
Prospective Licensee on or before February 21, 2001.

              (b) PAYMENT. Mossimo shall pay Finder's Fees to Cherokee within
fifteen (15) days after Mossimo's receipt of any Net Revenues. Payment of
Finder's Fees shall be accompanied by a written report setting forth the Net
Revenues actually received by Mossimo (broken down by date and amount received)
since the date of the last report delivered to Cherokee and such other
information as is necessary to enable Cherokee to verify the Net Revenues
reported by Mossimo. Finder's Fees shall be payable in United States Dollars.
Interest at the maximum legal rate shall be paid on any Finder's Fees not paid
when due.

              (c) NET REVENUES. "Net Revenues" shall mean all consideration of
any kind, without deductions or set-offs, received directly or indirectly by or
on behalf of Mossimo and its affiliates, successors and assigns from Target
Corporation or J.C. Penney Company, Inc., and their respective affiliates,
successors and assigns (collectively, "Prospective Licensees"), from and after
the Effective Date with respect to or by reason of any license, franchise, sale
or assignment of the Mossimo Trademarks. Mossimo shall not enter into any
agreement with Prospective Licensees pursuant to which Mossimo will receive any
consideration that is not included within Net Revenues.

                                       -2-

<PAGE>

        4. PRESS RELEASE. Within seven (7) days following the effective date of
any licensing agreement entered into between Mossimo and Prospective Licensees,
Mossimo shall issue a press release set forth as Exhibit "B" attached hereto.

        5. NO JOINT VENTURE: The parties hereto are not partners or joint
venturers. Cherokee shall have no liability with respect to Mossimo's business
or operations, Mossimo's negotiations with Prospective Licensees or any other
party, or the performance by Mossimo under any contract entered into with
Prospective Licensees or any other party. Mossimo is not responsible for any
actions of any third party regarding any license agreement entered into by
Mossimo.

        6. COUNTERPARTS. This Agreement may be executed by the parties hereto in
separate counterparts, each of so when executed shall be deemed to be an
original and all of which taken together shall constitute one and the same
agreement.

        7. SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
shall inure to the successors and assigns of the parties.

        8. MISCELLANEOUS. This Agreement expresses the complete understanding of
the parties with respect to the subject matter hereof. All prior understandings
are hereby canceled and no change in any term of this Agreement shall be binding
unless it is in writing and signed by Cherokee and Mossimo. This Agreement shall
be considered made in and shall be interpreted in accordance with the laws of
the State of California. Any disputes arising hereunder shall be arbitrated in
Los Angeles County, California in accordance with the rules and regulations of
the American Arbitration Association and the prevailing party in any such
arbitration shall be entitled to recover its legal fees and expenses from the
other party.

        9. NATURE OF AGREEMENT. The parties agree that this Agreement is not a
broker agreement and shall not be treated as such. The parties agree that
neither shall ever assert as a defense to a claim of breach of this Agreement or
any other agreement between them that this Agreement or the Prior Agreements are
illegal agreements.

        In witness whereof, the undersigned have executed this Agreement as of
the day and year first above written.

CHEROKEE INC.                                 MOSSIMO, INC.

/s/ Robert Margolis                           /s/ Mossimo Giannulli
----------------------------------            ----------------------------------
Robert Margolis                               Name: Mossimo Giannulli
Chairman and CEO                              Chairman

                                      -3-<PAGE>

===============================================================================
                                                                EXHIBIT 10.36

                                                                Redacted Version
================================================================================

                              DEALERSHIP AGREEMENT

         This Dealership Agreement ("Agreement") is entered into this 1st day of
October, 1999, (the "Effective Date") by and between OSTEX INTERNATIONAL, INC.,
a Washington corporation, 2203 Airport Way South, Suite 400, Seattle, Washington
98134 (hereinafter referred to as "Ostex") and PHYSICIAN SALES AND SERVICE,
INC., a Florida corporation, with offices at 4345 Southpoint Blvd.,
Jacksonville, FL 32216 (hereinafter referred to as "PSS").

                                   WITNESSETH:

In consideration of the mutual promises made herein, the parties agree as
follows:

1.       DEFINITIONS. As used herein:

         a)       "Territory" shall mean the U.S.A.

         b)       "Product" shall mean the Osteomark-registered trademark-
                  NTx/Creatinine quantitative point-of-care ("POC") device
                  manufactured exclusively for Ostex by Metrika, Inc.

         c)       "Office Market" shall mean office-based physicians, [ * ].

2.       GRANT OF DEALERSHIP.

         Ostex hereby grants PSS an exclusive Dealership to serve the Office
         Market in the Territory with respect to the promotion and sale of the
         Product. PSS accepts such Dealership and shall undertake its best
         efforts to promote the sale of the Product. PSS understands that Ostex
         has expended and will continue to expend substantial efforts and funds
         to secure and retain public goodwill toward the Product and its
         trademarks, and recognizes the vital interest to Ostex in the proper
         marketing of the Product. It shall be a material condition of this
         Agreement that PSS will sell the Product only to the Office Market
         within the Territory.

         It is expressly understood and agreed that although this Agreement is
         exclusive, Ostex may sell the Product to [ * ] for distribution to the
         Office Market in the Territory, provided the [ * ] distribute the
         Product with their own sales force and solely in connection with the
         marketing of [ * ] to the Office Market. During the term of this

-------------------------------
[*] Confidential Treatment Requested
<PAGE>

         Agreement, Ostex will 1not sell the Product to [ * ], for distribution
         to the Office Market in the Territory, [ * ]. Furthermore, if Ostex
         sells such Product to [ * ] at a [ * ] that Ostex sells the Product to
         PSS, Ostex will share [ * ] percent of the proceeds attributable to the
         [ * ] with PSS.

         During the term of this Agreement, and at any time that PSS is selling
         the Product, PSS shall not represent other products that compete with
         the Ostex Product.

3.       PRICING, SUPPLY, AND RETURNS.

         For the first [ * ] months of this Agreement, Ostex agrees to sell the
         Product to PSS at the price of [ * ] dollars [ * ] per [ * ]
         point-of-care devices.

         Prior to the Product achieving CLIA waiver status, Ostex agrees to
         provide PSS [ * ] urine controls and [ * ] point-of-care devices with
         every [ * ] point-of-care devices that PSS orders.

         After the Product achieves CLIA waiver status, Ostex agrees to sell to
         PSS urine controls for use with the Product at a price [ * ].

         Between the fifth and sixth month of this Agreement, the parties will
         review and may adjust the Product pricing (by no more than +/- [ * ])
         in view of the progressive rollout results. At that time the parties
         will also agree to minimum purchase requirements of the Product for the
         remaining term of this Agreement, commencing [ * ]. If at the end of
         any calendar year these performance expectations are not met, Ostex may
         at its sole discretion convert this Agreement to a [ * ] dealership or
         terminate this Agreement.

         Sales shall be FOB Seattle, WA, or Sunnyvale, CA.

         The terms of payment are net thirty (30) days of invoice date. Past due
         accounts are subject to a service and handling charge of 1 % per month.

         Within [ * ] days before the beginning of each calendar quarter, in
         consultation with Ostex, PSS will provide Ostex with a "Rolling
         Forecast" of PSS's requirements for Product for the twelve-month period
         commencing on the next calendar quarter. PSS's stated requirements for
         the first three-month period of each twelve-month period will
         constitute a firm purchase order that will obligate PSS to purchase the
         indicated number of Product devices. The forecasted demand for the
         fourth, fifth, and sixth months of each Rolling Forecast shall be
         relied upon by Ostex for the purposes of manufacturing and supply
         obligations hereunder, but PSS may within the subsequent Rolling
         Forecast vary its initial forecast for such months by no more than [ *
         ] percent ([ * ]%) of the aggregate

---------------------------------
[*] Confidential Treatment Requested

                                       2
<PAGE>

         unless agreed to by Ostex. The final [ * ] months of each Rolling
         Forecast will constitute non-binding estimates of PSS's requirements
         for the periods described therein.

         Ostex shall accept return of Product purchased by PSS under this
         Agreement under the following conditions: (i) the Product was
         originally shipped to PSS with less than [ * ] months shelf life; (ii)
         the Product is unopened and unused; (iii) PSS provides the necessary
         data for Ostex to authorize a return (e.g., lot number, expiration
         date, condition, and purchase order number of the Product). Upon
         receipt and confirmation of information requested, Ostex will issue a
         Return Material Authorization ("RMA") number that PSS must include on
         all paperwork that accompanies the returned Product (including the
         outside of the return packaging).

         Ostex shall also accept return of Product purchased by PSS under this
         Agreement in the event that Ostex becomes bankrupt or insolvent or
         undergoes a change of ownership.

4.       PRODUCT LAUNCH.

         Ostex will organize with the PSS Marketing team a progressive rollout
         of the Product on a [ * ] basis.

         PSS will establish with Ostex inventory minimums and sales goals by
         [*]. Minimum acceptable inventory will be [ * ] days.

5.       PSS'S RESPONSIBILITIES.

         a)       PSS agrees to actively promote the sale of the Product to the
                  Office Market in the Territory, to the best of PSS's ability
                  nationally, and to otherwise safeguard Ostex' interest
                  wherever possible. All promotional material will be reviewed
                  and approved by Ostex prior to PSS's use, in accordance with
                  Ostex' promotional and advertising policy.

         b)       PSS shall provide Ostex with monthly sales reports indicating
                  sales of Product to physicians by [ * ].

         c)       PSS agrees to keep Ostex informed about market trends and
                  conditions, experiences with customers, and major negotiations
                  and prospective sales possibilities.

         d)       PSS agrees to turn over to Ostex any and all leads from any
                  potential customers who are not in the Office Market.

         e)       PSS further agrees to assist Ostex in promoting the Osteomark
                  NTx assay [ * ], and to that end to transmit to Ostex
                  hereunder leads with respect to potential sales of NTx [ * ].

---------------------------------
[*] Confidential Treatment Requested

                                       3
<PAGE>

         f)       PSS agrees to provide at Ostex direction proper documentation
                  of PSS's handling of the Product to assure that OstexProduct
                  in PSS's possession complies with all orders, rules and
                  regulations issued by the FDA and QS Regulation.

         g)       PSS shall provide all in-service training for Product sold by
                  PSS to the Office Market.

         h)       PSS agrees not to alter the Product in any way and not to
                  remove the Ostex name, trademarks, or trade dress from the
                  Product or its packaging.

         i)       PSS shall provide a place of business with adequate
                  communications service to efficiently effect the business of
                  Product sales.

         j)       PSS shall maintain adequate inventory of Ostex sales materials
                  and technical information and make effective use of such items
                  in its best judgment.

6.       OSTEX RESPONSIBILITIES

         a)       Ostex will provide assistance to the PSS Marketing team in
                  launching the Product [ * ].

         b)       Ostex will at its option support PSS's annual national sales
                  meeting at [ * ] for the first year, and thereafter at invited
                  [ * ]. Additionally, Ostex will participate in quarterly
                  promotions to include Platinum Plus promotions.

         c)       Ostex shall provide an 800 support number for PSS and
                  customers.

         d)       Ostex shall provide PSS with a reasonable quantity of
                  promotional materials to assist in PSS's marketing efforts.
                  Additional promotional materials can be purchased from Ostex [
                  * ].

         e)       Ostex shall turn over to PSS all Office Market leads for the
                  Product but not for other Ostex products.

         f)       Ostex will provide a product video or computer display for use
                  in the sales activities of PSS's sales personnel.

---------------------------------
[*] Confidential Treatment Requested

                                       4
<PAGE>

7.       CONFIDENTIAL INFORMATION

         PSS and Ostex agree not to make available or accessible to any third
         party or use except as authorized for the purposes of performing this
         Agreement any technical or commercial data or other information of a
         competitive, special or confidential nature, transmitted to either
         party by the other, and this undertaking shall continue to be
         applicable for a period of [ * ] following the expiration or
         termination of the Agreement for whatever cause. However, upon
         expiration or termination of this agreement PSS will promptly provide
         sufficient customer information to Ostex so that Ostex to can continue
         to service such existing customers of the Product in the Office Market.

8.       INSURANCE

         PSS shall procure and maintain in full force and effect during the term
         of this Agreement an insurance policy or policies, protecting PSS, its
         officers, directors, employees and agents against any loss, liability
         or expense whatsoever, arising out of or in connection with PSS's sale
         of the Product.

         Ostex shall indemnify and hold harmless PSS and its agents, employees,
         officers and directors from claims relating to the use of the Product,
         product liability, warranty claims and all matters relating to the
         Product except to the extent that the claim arises from or is related
         to the acts, omissions or misrepresentations of the PSS, its employees,
         officers, directors and agents.

         Ostex shall secure Product liability insurance in an amount not less
         than [ * ] and shall secure a vendor endorsement naming PSS as an
         additional insured.

9.       TRADE SHOWS AND TRAINING COURSES.

         a)       PSS agrees to display and promote the Product at a reasonable
                  number of local meetings or exhibits as they may arise, at its
                  sole cost and expense. All exhibit material developed for and
                  all promotional material distributed at such local meetings
                  and exhibits will be reviewed and approved by Ostex prior to
                  use, in accordance with Ostex promotion and advertising
                  policy.

         b)       From time to time, PSS agrees to send select members of its
                  sales and marketing group to Ostex for training, at PSS's sole
                  cost and expense. Ostex agrees to provide appropriate training
                  to PSS's employees at PSS's locations at [ * ].

---------------------------------
[*] Confidential Treatment Requested

                                       5
<PAGE>

10.      OSTEX NAME AND TRADEMARK

         In the event the PSS wishes to fix a label on the outer packaging box
         containing the Products, showing that the PSS has an Ostex Dealership,
         PSS agrees to coordinate with Ostex in advance the manner, size,
         location and appearance of such label.

         PSS shall use the name Ostex and the Ostex-registered trademark- and
         Osteomark-registered trademark- trademarks only for the duration of
         this Agreement and only for the design of marketing materials for the
         Product, and only after having obtained specific prior approval in
         writing from Ostex. PSS will, therefore, submit all such proposals to
         Ostex for approval.

         PSS agrees to immediately cease use of the name Ostex and the
         Ostex-registered trademark- and Osteomark-registered trademark-
         trademarks upon expiration or termination of this Agreement.

11.      TERM OF THE AGREEMENT

         This Agreement shall come into effect on the Effective Date set forth
         above, and shall continue for a period of [ * ] years from the
         Effective Date, unless terminated earlier as provided herein.

         This Agreement shall be automatically renewed for successive [ * ]
         periods, unless either party notifies the other party in writing of its
         intention not to renew this Agreement at least [ * ] days prior to the
         expiration of the then current term.

12.      IMMEDIATE TERMINATION PRIOR TO EXPIRATION OF THE AGREEMENT

         Either party shall have the right to terminate this Agreement with
         immediate effect during the term of the Agreement if the other party
         shall be adjudged bankrupt or insolvent, or shall become insolvent, or
         if a receiver or other officer is appointed by any court or
         governmental authority to administer or liquidate the company, or in
         the event of dissolution proceedings by or against said other party.

13.      TERMINATION WITH CAUSE

         Either party shall have the right to terminate this Agreement in the
         event that the other party defaults in the material performance of this
         Agreement and continues in default thereof after [ * ] days' written
         notice by the first party of such default. During this [ * ] day cure
         period the parties agree to discuss the conflict at senior levels with
         the goal of resolving the conflict without termination or litigation.
         If the conflict is not resolved within the [ * ] day cure period, the
         notifying party may terminate the Agreement or, if the notifying party
         is Ostex, convert this Agreement to a nonexclusive dealership. If Ostex
         terminates this Agreement following the [ * ] day cure period, Ostex
         must provide

---------------------------------
[*] Confidential Treatment Requested

                                       6
<PAGE>

         an additional [ * ] day separation period during which PSS can sell its
         inventory of Product.

14.     TERMINATION WITHOUT CAUSE

         Either party shall have the right to terminate this Agreement, without
         cause, upon [ * ] months prior written notice.

15.      UNDERTAKINGS RELATED TO TERMINATION

         Upon termination or expiration of this Agreement for whatever cause:

         a)       PSS agrees to return Ostex immediately after such termination
                  or expiration, or separation period, all written materials
                  forwarded by Ostex to PSS hereunder.

         b)       Ostex shall have the option to purchase from PSS, exercisable
                  in Ostex's sole discretion, and PSS agrees to sell to Ostex at
                  the price that PSS paid to Ostex, any or all Ostex Product to
                  which PSS has title upon said termination or expiration.

         c)       PSS agrees that no obligation shall exist for Ostex to
                  indemnify PSS for damages of any kind pertaining to PSS's
                  investment in the promotion of the Product, it being
                  understood that the PSS price permits a sufficient return on
                  investment.

16.      AMENDMENTS

         This Agreement cannot be amended except in writing duly signed by an
         authorized representative of Ostex and PSS.

17.      NON-ASSIGNABILITY

         The Agreement shall not be assignable by either party without the
         written consent of the other, except that Ostex may assign this
         Agreement to any affiliated Ostex company without consent. Any
         attempted assignment in violation hereof shall be void.

18.      NOTICES

         All notices required to be given hereunder shall be deemed given if in
         writing and deposited in the United States mail in a sealed envelope,
         certified, with postage thereon prepaid and addressed to Ostex or PSS,
         at the addresses listed on page 1 of this Agreement or at such other
         address as the parties may direct by notice given as herein provided.

---------------------------------
[*] Confidential Treatment Requested

                                       7
<PAGE>

19.      INDEPENDENT CONTRACTOR

         Each of the parties is an independent contractor. Neither party has any
         authority, expressed or implied, to act for the other in dealings with
         others, and neither shall purport to act as the agent or employee of
         the other. PSS and Ostex shall be responsible for compliance with all
         laws and regulations governing their respective businesses, and will
         hold the other party harmless from all claims arising out of its
         conduct. No employee of PSS shall be deemed in any manner whatsoever to
         be an employee of Ostex, and as such shall not be entitled to and is
         not qualified under any employee benefit plans provided by Ostex for
         Ostex employees. The employees of PSS shall not be entitled to
         participate in any plans, arrangements or distributions by Ostex
         pertaining to, or in connection with, any bonus, pension, health,
         insurance, welfare or similar benefit plan offered by Ostex to
         employees. PSS and its employees shall be solely responsible for any
         and all city, state and federal income taxes, social security
         withholding taxes and any other tax obligation to which the employees
         of PSS may be subjects. Ostex shall not be responsible for any payments
         due to or on account of PSS's employees in connection with the
         Agreement.

20.      WAIVER

         The waiver by either party of a default or breach of any provision of
         this Agreement by the other party shall not operate or be construed as
         a waiver of any subsequent default or breach.

21.      ARBITRATION.

         In the event of any controversy or threatened breach arising under or
         relating to this Agreement, the parties agree to submit such issue to
         arbitration at an office of the American Arbitration Association,
         according to the rules and regulations of that Association. The
         arbitration shall take place in Seattle, WA if initiated by PSS, or in
         Jacksonville, FL if initiated by Ostex. The arbitrators shall be
         authorized to award the costs and expenses of arbitration to the
         prevailing party. Judgment on an arbitration award entered pursuant to
         a vote duly taken may be entered in any court of competent
         jurisdiction.

         The party desiring arbitration shall give written notice to that effect
         to the other party, stating the dispute to be arbitrated and the name
         and address of the person designated to act as arbitrator on its
         behalf. Within ten (10) days after said notice shall be given, the
         other party shall give written notice to the first party, stating the
         name and address of the person designated to act as arbitrator on its
         behalf. In the event that the second party shall fail to notify the
         first party of its designation of an arbitrator as aforesaid within the
         time above specified, then the appointment of the second arbitrator
         shall be made in the same manner as hereinafter provided for the
         appointment of a third arbitrator by the American Arbitration
         Association. The arbitrators so chosen shall meet within ten (10) days
         after the second arbitrator shall be appointed and within thirty (30)
         days thereafter shall decide the controversy they were appointed to
         arbitrate.

                                       8
<PAGE>

         In the event that within the aforesaid period, the two arbitrators
         shall be unable to agree on a decision they shall appoint a third
         arbitrator, and if they cannot agree on said appointment, the third
         arbitrator shall be appointed on their application or on the
         application of either party, by the American Arbitration Association.
         The three (3) arbitrators shall meet and decide the dispute. A decision
         in which two (2) of the three (3) arbitrators shall concur shall be
         binding and conclusive on the parties. In designating arbitrators and
         deciding the dispute, the arbitrators shall act according to the rules
         then in force of the American Arbitration Association, subject,
         however, to such limitations as the provisions of this Agreement may
         place on them.

         Any claims for breach of this Agreement or any cause of action
         whatsoever arising out of, or in any way related to this Agreement,
         shall be waived and forfeited, unless asserted by the claiming party by
         commencement of an arbitration proceeding with respect to such breach
         within one (1) year after the claiming party has become aware of the
         claim.

         In the event any proceeding is brought to enforce or interpret any of
         the terms of this Agreement, including Ostex Standard Terms and
         Conditions of Sale or policies, the prevailing party shall be entitled
         to recover from the other party all reasonable attorney's fees,
         together with such other expenses, costs and disbursements as may be
         allowed by law.

22.      ENTIRE AGREEMENT

         This Agreement constitutes the entire agreement between Ostex and PSS,
         is a complete and exclusive statement, and supersedes all previous
         agreements of any kind concerning the subject matter and scope hereof.

23.      CHOICE OF LAW

         This Agreement shall be governed by and interpreted under the laws of
the State of Washington without regard to the conflicts of laws rules thereof.

Accepted:

OSTEX INTERNATIONAL, INC.                   PHYSICIAN SALES AND SERVICE, INC.

Name:        THOMAS A. BOLOGNA                       D. J. HARPER
     --------------------------------      -------------------------------------

Signature:  /s/ THOMAS A. BOLOGNA                   /S/ D. J. HARPER
         ------------------------------    ------------------------------------

Title:     Chairman, President & CEO          Senior Vice President

Date:        OCTOBER 7,1999                           11/10/99
    ----------------------------------     ------------------------------------

                                       9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}]]